Biochemical and pharmacological characterization of the human lymphocyte antigen B-associated transcript 5 (BAT5/ABHD16A).
<h4>Background</h4>Human lymphocyte antigen B-associated transcript 5 (BAT5, also known as ABHD16A) is a poorly characterized 63 kDa protein belonging to the α/β-hydrolase domain (ABHD) containing family of metabolic serine hydrolases. Its natural substrates and biochemical properties ar...
Enregistré dans:
Auteurs principaux: | Juha R Savinainen, Jayendra Z Patel, Teija Parkkari, Dina Navia-Paldanius, Joona J T Marjamaa, Tuomo Laitinen, Tapio Nevalainen, Jarmo T Laitinen |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Public Library of Science (PLoS)
2014
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/7badfbd1be224b0b86ab6594956a58a2 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Discovery of triterpenoids as reversible inhibitors of α/β-hydrolase domain containing 12 (ABHD12).
par: Teija Parkkari, et autres
Publié: (2014) -
Macrophage ABHD5 promotes colorectal cancer growth by suppressing spermidine production by SRM
par: Hongming Miao, et autres
Publié: (2016) -
ABHD5 blunts the sensitivity of colorectal cancer to fluorouracil via promoting autophagic uracil yield
par: Juanjuan Ou, et autres
Publié: (2019) - Biochemical pharmacology
-
ABHD5 inhibits YAP-induced c-Met overexpression and colon cancer cell stemness via suppressing YAP methylation
par: Yan Gu, et autres
Publié: (2021)